List of Studies ( Metabolite:Dimethyl sulfoxide)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004377 | AN007313 | Metabolomic analysis of WT and TRAP1 KO HEK293 cells in the presence or absence of the mitochondrial Hsp90 inhibitor Gamitrinib-TPP. | Cultured cells | Human | Cancer | SUNY Upstate Medical University | LC-MS |
| ST003768 | AN006185 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Leaf | Grass | Hunan Agricultural University | LC-MS | |
| ST003768 | AN006185 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Roots | Grass | Hunan Agricultural University | LC-MS | |
| ST003736 | AN006130 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass (Rumex patientia L.× Rumex tianschanicus A. LOS) | Rhizosphere | Rumex patientia | Hunan Agricultural University | LC-MS | |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Blood | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Brain | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Heart | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Liver | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003435 | AN005644 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Media | Zebrafish | Cancer | Wistar Institute | LC-MS |
| ST003434 | AN005642 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Blood | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003362 | AN005504 | Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST003362 | AN005506 | Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST003356 | AN005497 | Noninvasive multiomic measurement of cell type repertoires in human urine | Urine | Human | Urinary tract infection | CZ Biohub | LC-MS |
| ST003307 | AN005418 | Untargeted metabolomics of rhizosphere soil from 4-years Panax ginseng that was treated with endo-borneol under field condition | Soil | Panax ginseng | Yunnan University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | LC-MS | |
| ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
| ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
| ST002711 | AN004393 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: biogenic amines | Blood | Human | Autism | Columbia University | LC-MS |
| ST002510 | AN004133 | Strain supernatants: Strain diversity of Eggerthella lenta metabolites in defined media | Bacterial media | Eggerthella lenta | University of California, San Francisco | LC-MS | |
| ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002075 | AN003382 | Profiling of the human intestinal microbiome and bile acids under physiologic conditions using an ingestible sampling device (Part 2) | Intestine | Human | University of California, Davis | LC-MS | |
| ST002028 | AN003298 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Feces | Human | University of California, Davis | LC-MS | |
| ST001888 | AN003057 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001876 | AN003038 | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001876 | AN003038 | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001637 | AN002675 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001122 | AN001847 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) | Urine | Human | Interstitial cystitis | University of California, Davis | LC-MS |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000356 | AN000583 | GC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum data | Blood | Human | Cancer | University of Hawaii | GC-MS/LC-MS |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
